Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study

被引:3
|
作者
Gulpen, Anouk J. W. [1 ,2 ,3 ]
Braeken, Dionne C. W. [1 ]
Schalla, Simon [2 ,4 ]
Ten Cate, Hugo [1 ,2 ,3 ]
Crijns, Harry J. [2 ,4 ]
Ten Cate-Hoek, Arina J. [1 ,2 ]
机构
[1] Maastricht & Lab Clin Thrombosis & Hemostasis, Thrombosis Expert Ctr, Maastricht, Netherlands
[2] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands
[3] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[4] Maastricht Univ, Med Ctr, Dept Cardiol & Radiol, Maastricht, Netherlands
关键词
Direct oral anticoagulants; Thrombosis; Adherence; WARFARIN; DABIGATRAN; PERSISTENCE; APIXABAN; THERAPY; SCALE;
D O I
10.1159/000524094
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Long-term treatment with direct oral anticoagulants (DOAC) is required for the majority of patients with nonvalvular atrial fibrillation (AF) to prevent ischemic stroke and systemic embolism. Adherence to therapy may impact clinical outcomes. Therefore, the purpose of this study was to assess the potential impact of structured follow-up on long-term adherence to DOAC therapy compared to standard care. Methods: This is a cross sectional study on the implementation phase of medication adherence to DOACs, comparing patients with AF following completion of structured follow-up of minimally 1 year with those who received standard care. All patients used DOACs for more than 2 years and completed a questionnaire on adherence. Adherence was measured with the Morisky Medication Adherence Scale-8 (MMAS-8) score and assessed via an online web portal. Results: A total of 212 patients were included. The mean MMAS-8 score was 7.55 (SD 0.93) after structured follow-up and 7.25 (SD 1.01) for standard care; p = 0.045. Following structured follow-up 64.1% of patients had a high adherence (MMAS score of 8) compared to 50% receiving standard care; p = 0.05. Patients following structured follow-up on a once daily DOAC regime had higher MMAS-8 scores compared to those on a twice daily regime; 7.74 (SD 0.74) versus 7.00 (SD 1.22); p < 0.001. The rates of minor bleedings were 10.6% versus 21.4% respectively, p = 0.038. Conclusion: In patients on long-term DOAC treatment, adherence to therapy was significantly increased after receiving an initial period of structured follow-up compared to standard care. Additionally, adherence to DOAC therapy was higher with once-daily treatment regimen. Significant more minor bleedings were reported in the standard care group. These results indicate that implementation of structured follow-up of patients with AF using DOACs merits further evaluation. (c) 2022 The Author(s). Published by S. Karger AG, Basel
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [31] Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
    Banerjee, Amitava
    Benedetto, Valerio
    Gichuru, Philip
    Burnell, Jane
    Antoniou, Sotiris
    Schilling, Richard J.
    Strain, William David
    Ryan, Ronan
    Watkins, Caroline
    Marshall, Tom
    Sutton, Chris J.
    HEART, 2020, 106 (02) : 119 - +
  • [32] Assessment of Knowledge and Medication Adherence Among Patients Prescribed with Oral Anticoagulants in Atrial Fibrillation at a Tertiary Care Centre: A Cross Sectional Study
    Khanal, Pooja
    Bista, Durga
    Shrestha, Rojeena Koju
    JOURNAL OF BLOOD MEDICINE, 2024, 15 : 533 - 547
  • [33] Association of Depression and Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
    Lapa, Matthew
    Magnani, Jared W.
    CIRCULATION, 2022, 146
  • [34] Determinants of adherence to oral anticoagulants in patients with atrial fibrillation and stroke
    Polymeris, A.
    Traenka, C.
    Hert, L.
    Seiffge, D. J.
    Peters, N.
    de Marchis, G. M.
    Bonati, L.
    Lyrer, P. A.
    Engelter, S. T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 363 - 363
  • [35] Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
    Garkina, Svetlana V.
    Vavilova, Tatiana V.
    Lebedev, Dmitry S.
    Mikhaylov, Evgeny N.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2016, 13 (09) : 807 - 810
  • [36] Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
    Svetlana V Garkina
    Tatiana V Vavilova
    Dmitry S Lebedev
    Evgeny N Mikhaylov
    Journal of Geriatric Cardiology, 2016, 13 (09) : 807 - 810
  • [37] Utilization and long-term persistence of direct oral anticoagulants among patients with non-valvular atrial fibrillation and liver disease
    Douros, Antonios
    Cui, Ying
    Platt, Robert W.
    Filion, Kristian B.
    Sebastiani, Giada
    Renoux, Christel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 632 - 633
  • [38] Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
    Simon Schwill
    Katja Krug
    Frank Peters-Klimm
    Jan van Lieshout
    Gunter Laux
    Joachim Szecsenyi
    Michel Wensing
    BMC Family Practice, 19
  • [39] Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
    Schwill, Simon
    Krug, Katja
    Peters-Klimm, Frank
    van Lieshout, Jan
    Laux, Gunter
    Szecsenyi, Joachim
    Wensing, Michel
    BMC FAMILY PRACTICE, 2018, 19
  • [40] ADHERENCE TO LONG-TERM THERAPY IN CARDIOVASCULAR PATIENTS WITH ATRIAL FIBRILLATION
    Konobeeva, E., V
    Sokolov, I. M.
    Potapova, M., V
    Gafanovich, E. Y.
    Zheleznyakova, N. A.
    Tsymbal, A. A.
    NEW ARMENIAN MEDICAL JOURNAL, 2020, 14 (02): : 79 - 83